Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Search results for

There are 22,213 results that match your search.22,213 results
  • In Lyons v American College of Veterinary Sports Medicine and Rehabilitation, the US Court of Appeals for the Federal Circuit addressed a dispute regarding the proper owner of a service mark when there has been a departure from or change of membership in a group and both the departing party and the remnant group claim ownership of the mark. In so doing, the Court highlighted the importance for ventures to enter into formal agreements memorializing ownership of a mark.
  • A new bilateral agreement promises mutual recognition of certain geographical indications from Europe and China. Katharina König and Matthew Murphy explain
  • Reforms are coming in Australia as the government responds to the Productivity Commission inquiry into IP arrangements. Karry Lai reports
  • How do US, UK and EPO tribunals compare when it comes to patent infringement disputes? Ilya Kazi contrasts tactics and procedures, drawing on lessons from recent cases
  • Chugai Pharmaceutical sought an injunction against DKSH's importation of maxacalcitol active pharmaceutical ingredient and against Iwaki Seiyaku etc's sales of the defendants' products. A judgment to the following effect became final and binding: the manufacturing method in question was considered to be equivalent to the patented invention and to fall within its technical scope (judgment of March 24 2017, the Supreme Court and judgment of March 25 2016, the Grand Panel of the IP High Court).
  • The Federal Court of Canada recently issued its public judgment and reasons concerning the financial compensation to be paid to AstraZeneca as a result of Apotex's infringement of the omeprazole formulation patent (AstraZeneca's Losec) in AstraZeneca Canada Inc v Apotex Inc, 2017 FC 726. During the liability phase of these proceedings, the Federal Court of Canada had found the omeprazole formulation patent valid and infringed by Apotex (AstraZeneca Canada Inc v Apotex Inc, 2015 FC 322).
  • Is the UK Supreme Court’s decision in Actavis v Eli Lilly a radical change to English patent law? Brian Cordery, Annsley Merelle Ward and Adrian Chew say it may not be quite as simple as that
  • As we know, the Madrid System is a tool that simplifies the administrative procedure of trade marks through an International Registration which is equivalent to various national registrations by the applicant in the designated contracting parties.
  • The European Commission has issued its position paper on pan-European Union IP rights post-Brexit. As patents are not governed by the EU but come under the remit of European Patent Office, they are unaffected by Brexit and are not included in the document. Thus the EU need only concern itself with other IP rights, mainly trade marks and designs.
  • Spain’s courts imported the old English test into their patent law. Miquel Montañá asks: now that test has changed, will they have to change too?